5 Most Promising Penny Stocks According to Wall Street Analysts

Page 5 of 5

1. Alvotech (NASDAQ:ALVO)

Average Upside Potential: 135.51%

Alvotech (NASDAQ:ALVO) is one of the most promising penny stocks according to Wall Street analysts. On May 11, Alvotech announced the completion of a routine FDA surveillance inspection at its manufacturing facility in Reykjavik, Iceland. While the FDA issued a Form 483 at the conclusion of the visit on May 8, 2026, the company stated that it believes the observations are manageable and do not indicate significant issues with the site’s overall operations or compliance.

Management views the results as a validation of the facility’s current cGMP fundamentals and the effectiveness of improvements implemented over the past year. Consequently, the company remains on schedule to resubmit its relevant BLAs during Q2 2026.

Alvotech (NASDAQ:ALVO) maintains its outlook for achieving FDA approval for these BLAs within the 2026 calendar year. The company continues to focus on finalizing the necessary data compilation to support the upcoming regulatory submissions.

Alvotech (NASDAQ:ALVO) is a biotechnology company that develops and manufactures biosimilar medicines. The firm’s focus is on the development of its product candidates, with its operations divided into the following geographical segments: Europe, North America, Asia, and Other.

While we acknowledge the potential of ALVO to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than ALVO and that has 100x upside potential, check out our report about the cheapest AI stock.

READ NEXT: 10 Best Low Priced Stocks to Buy for the Next 3 Years and 12 Best Low Priced Growth Stocks to Invest In Now.

Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.

Page 5 of 5
1281292 - 11759070 - 1